New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 8, 2014
07:44 EDTMNK, QCORMallinckrodt remains favorite specialty pharmaceutical name, says UBS
UBS said Mallinckrodt (MNK) remains its favorite specialty pharmaceutical name following the company's update on its merger with Questcor (QCOR). The firm sees estimates increasing following the close of the transaction, the divestiture of the Medical Imaging division, and the reinvestment in higher margin assets. UBS has a Buy rating with a $94 price target on Mallinckrodt.
News For MNK;QCOR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 27, 2014
07:23 EDTMNKAmerican College of Surgeons holds a conference
Subscribe for More Information
October 23, 2014
10:01 EDTMNKOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:20 EDTMNKMallinckrodt initiated with a Buy at Guggenheim
Subscribe for More Information
October 20, 2014
07:12 EDTMNKCongress of Neurological Surgeons to hold annual meeting
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use